Starting at $ 115 / Month GLP-1 receptor agonist that is FDA-approved for chronic weight management Wegovy Adults with obesity (BMI 30) or overweight (BMI 27 with a weight-related condition such as hypertension, diabetes, or high cholesterol) Start todayMore Info Potential Weight Loss* Administration methods** Injections Dose frequency*** Weekly Potential side effects Possible side effects may include nausea, vomiting, constipation, diarrhea, indigestion or stomach discomfort, reduced appetite, headache, fatigue, or injection site reactionsespecially when starting or increasing the dose
Same destination weight loss and better metabolic health but now were using a very different GPS and occasionally missing a few turns along the way. For those who prefer to work with a human, Berjis explains that her InnerHealthWellness app can offer the best of both worlds
GLP-1 receptor agonists overview. Davies M, et al
Long-term berberine use, specifically, has limited safety data